scholarly journals Septic arthritis of the hips in adults with sickle cell anemia

2011 ◽  
Vol 3 (1) ◽  
pp. 1 ◽  
Author(s):  
Alexandre Poignard ◽  
Mohamed Bouhou ◽  
Yasuhiro Homma ◽  
Philippe Hernigou

Although the presence of osteonecrotic bone is known to make joints more prone to infection, acute septic joint in hip osteonecrosis has not frequently been reported in adults with sickle cell disease. The clinical features at the time of admission, imaging findings suggesting the diagnosis, modes of treatment and sequelae of septic arthritis of twenty-four hip joints with osteonecrosis in patients with sickle cell disease were studied retrospectively over a 25-years period. This study evaluated also the complications, the efficiency and the risk of total hip arthroplasty in these patients. Most patients were in the third decade of life. Staphylococcus and Gram negative infection predominated. Treatment was first conservative but most of the patients needed surgery to treat infection and sequelae related to infection. A total hip arthroplasty was performed later in twenty joints. No deaths were observed, but complications occurred. Twenty of the patients in our study underwent delayed total hip arthroplasties following repeated aspirations of the joint and intravenous antibiotics. With an experienced surgical and medical team and multidisciplinary management of these patients undergoing total hip arthroplasty after hip infection, our rate of complications was acceptable.

Hematology ◽  
2019 ◽  
Vol 2019 (1) ◽  
pp. 351-358 ◽  
Author(s):  
Oyebimpe O. Adesina ◽  
Lynne D. Neumayr

Abstract Osteonecrosis, a form of ischemic bone injury that leads to degenerative joint disease, affects ∼30% of people with sickle cell disease. Although osteonecrosis most commonly affects the femoral head (often bilaterally, with asymmetric clinical and radiographic progression), many people with sickle cell disease also present with multifocal joint involvement. We present the case of a young woman with bilateral osteonecrosis of the femoral head at varying stages of progression; we also highlight other important comorbid complications (eg, chronic pain requiring long-term opioids, debility, and social isolation) and postoperative outcomes. In this review, partly based on recommendations on osteonecrosis management from the 2014 evidence-based report on sickle cell disease from the National Heart, Lung and Blood Institutes, we also discuss early signs or symptoms of osteonecrosis of the femoral head, radiographic diagnosis and staging criteria, hydroxyurea effect on progression to femoral head collapse, and surgical outcomes of total hip arthroplasty in the modern era. In summary, we failed to find an association between hydroxyurea use and femoral head osteonecrosis; we also showed that evidence-based perioperative sickle cell disease management resulted in superior postoperative outcomes after cementless total hip arthroplasty in sickle cell–related osteonecrosis of the femoral head.


2018 ◽  
Vol 43 (2) ◽  
pp. 293-298 ◽  
Author(s):  
Mohamed Zubair Farook ◽  
Moji Awogbade ◽  
Karthik Somasundaram ◽  
Ines L. H. Reichert ◽  
Patrick L. S. Li

2020 ◽  
Vol 35 (8) ◽  
pp. 2286-2295
Author(s):  
Safa C. Fassihi ◽  
Ryan Lee ◽  
Theodore Quan ◽  
Andrew A. Tran ◽  
Seth N. Stake ◽  
...  

2020 ◽  
Vol 23 (10) ◽  
pp. 1426
Author(s):  
ME Ugbeye ◽  
W Lawal ◽  
O Ayodabo ◽  
EM Dim ◽  
S Adegoke

Sign in / Sign up

Export Citation Format

Share Document